ENDPOINTS NEWS8 分钟
Verve is lat­est gene edit­ing com­pa­ny to suf­fer set­back as Ver­tex walks away ...
Vertex Pharmaceuticals exits liver disease gene editing program with Verve Therapeutics. Verve continues work on a separate ...